United Asset Strategies, Inc. Abb Vie Inc. Transaction History

United Asset Strategies, Inc.

$1.07 Billion
Q3 2024

A detailed history of United Asset Strategies, Inc. transactions in Abb Vie Inc. stock. As of the latest transaction made, United Asset Strategies, Inc. holds 13,941 shares of ABBV stock, worth $2.51 Million. This represents 0.26% of its overall portfolio holdings.

Number of Shares

13,941

Previous 13,519 3.12%

Holding current value

$2.51 Million

Previous $2.32 Million 18.77%

% of portfolio

0.26%

Previous 0.23%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 28, 2024	BUY	$163.84 - $199.33 $69,140 - $84,117	422 Added 3.12%	13,941 $2.75 Million
Q2 2024 Aug 01, 2024	SELL	$154.79 - $180.76 $108,043 - $126,170	-698 Reduced 4.91%	13,519 $2.32 Million
Q1 2024 Apr 23, 2024	BUY	$159.82 - $182.1 $47,626 - $54,265	298 Added 2.14%	14,217 $2.59 Million
Q4 2023 Jan 30, 2024	BUY	$137.6 - $154.97 $243,827 - $274,606	1,772 Added 14.59%	13,919 $2.16 Million
Q3 2023 Nov 07, 2023	BUY	$133.59 - $154.65 $20,038 - $23,197	150 Added 1.25%	12,147 $1.81 Million
Q2 2023 Jul 25, 2023	SELL	$132.51 - $164.9 $604,113 - $751,779	-4,559 Reduced 27.54%	11,997 $1.62 Million
Q1 2023 Apr 25, 2023	BUY	$144.61 - $166.54 $34,127 - $39,303	236 Added 1.45%	16,556 $2.64 Million
Q4 2022 Jan 26, 2023	BUY	$138.31 - $165.87 $151,449 - $181,627	1,095 Added 7.19%	16,320 $0
Q3 2022 Oct 24, 2022	BUY	$134.21 - $153.93 $62,541 - $71,731	466 Added 3.16%	15,225 $2.04 Million
Q2 2022 Aug 15, 2022	BUY	$137.62 - $174.96 $18,991 - $24,144	138 Added 0.94%	14,759 $2.26 Million
Q1 2022 Apr 29, 2022	SELL	$131.98 - $163.75 $4.94 Million - $6.13 Million	-37,440 Reduced 71.92%	14,621 $2.37 Million
Q4 2021 Jan 31, 2022	BUY	$107.43 - $135.93 $527,159 - $667,008	4,907 Added 10.41%	52,061 $7.05 Million
Q3 2021 Oct 21, 2021	BUY	$106.4 - $120.78 $293,132 - $332,748	2,755 Added 6.21%	47,154 $5.09 Million
Q2 2021 Jul 19, 2021	BUY	$105.21 - $117.21 $360,975 - $402,147	3,431 Added 8.37%	44,399 $5 Million
Q1 2021 Apr 27, 2021	BUY	$102.3 - $112.62 $1.64 Million - $1.8 Million	15,996 Added 64.06%	40,968 $4.43 Million
Q4 2020 Feb 05, 2021	SELL	$80.49 - $108.67 $2,656 - $3,586	-33 Reduced 0.13%	24,972 $2.68 Million
Q3 2020 Nov 03, 2020	SELL	$85.91 - $100.83 $74,655 - $87,621	-869 Reduced 3.36%	25,005 $2.19 Million
Q2 2020 Aug 03, 2020	BUY	$73.37 - $98.18 $1.9 Million - $2.54 Million	25,874 New	25,874 $2.54 Million

Others Institutions Holding ABBV

# of Institutions

3,853

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $318B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of United Asset Strategies, Inc., based on Form 13F filings with the SEC.

News

Stay updated on United Asset Strategies, Inc. with notifications on news.

Account

United Asset Strategies, Inc. Abb Vie Inc. Transaction History